New therapies bring hope after much frustration
The Journal of Community and Supportive Oncology. 2016 February;14(2):79-84 | 10.12788/jcso.0199
February 21, 2016|The Journal of Community and Supportive Oncology
Collectively representing numerous distinct cancers, gastrointestinal (GI) malignancies are a major health burden worldwide. Despite the development of numerous targeted therapies that have advanced the treatment of several GI cancer types, current treatment options have afforded only modest improvements in survival. Here, we discuss how valuable insights gained from both successes and failures are fostering hope for new therapies.
Click on the PDF icon at the top of this introduction to read the full article.
